Xi N. Zhang

No. 115 Donghu Road
Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 177 publications

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

Sirolimus-based treatment regimens for antinuclear antibody (ANA)-positive immune thrombocytopenia: a retrospective single-center cohort study.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 25, 2026

Emerging strategies for the prevention and management of chronic graft-versus-host disease.

Emerging strategies for the prevention and management of chronic graft-versus-host disease.

Journal: Expert opinion on biological therapy

Published: April 22, 2026

A Bone Marrow-Targeted Nanomodulator as a Histone Lactylation Inhibitor for Reversing Immune Tolerance in Multiple Myeloma.

A Bone Marrow-Targeted Nanomodulator as a Histone Lactylation Inhibitor for Reversing Immune Tolerance in Multiple Myeloma.

Journal: ACS nano

Published: April 21, 2026

Ferroptotic stress promotes hematopoietic stem cell aging through S1P-dependent epigenetic and lipid remodeling.

Ferroptotic stress promotes hematopoietic stem cell aging through S1P-dependent epigenetic and lipid remodeling.

Journal: Blood

Published: March 24, 2026

Efficacy and safety of TPO-RA combined with sirolimus in the treatment of relapsed immune thrombocytopenia.

Efficacy and safety of TPO-RA combined with sirolimus in the treatment of relapsed immune thrombocytopenia.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 17, 2026

EV-Mediated Oncogenic Regulation in Lung Cancer and Clinical Translation: From Liquid Biopsy to Targeted Delivery Systems.

EV-Mediated Oncogenic Regulation in Lung Cancer and Clinical Translation: From Liquid Biopsy to Targeted Delivery Systems.

Journal: International journal of nanomedicine

Published: January 16, 2026

Patient-reported outcomes in chronic GVHD: instruments, clinical utility, and survivorship integration.

Patient-reported outcomes in chronic GVHD: instruments, clinical utility, and survivorship integration.

Journal: Journal of patient-reported outcomes

Published: January 02, 2026

Robot-assisted management of pulp canal obliteration: an in vitrostudy

Robot-assisted management of pulp canal obliteration: an in vitrostudy

Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology

Published: December 30, 2025

Schisandrol A induces cardiac developmental toxicity in zebrafish (Danio rerio) via disruption of calcium homeostasis, oxidative stress, and apoptosis.

Schisandrol A induces cardiac developmental toxicity in zebrafish (Danio rerio) via disruption of calcium homeostasis, oxidative stress, and apoptosis.

Journal: Toxicology and applied pharmacology

Published: December 14, 2025

Management of CMV Pneumonia, DAH, and BOS Following HSCT in a Child with β-Thalassemia: A Case Report.

Management of CMV Pneumonia, DAH, and BOS Following HSCT in a Child with β-Thalassemia: A Case Report.

Journal: Journal of inflammation research

Published: December 11, 2025

A novel Skp2 inhibitor triggers pyroptosis in leukemia via phospholipid metabolism disorder and mitochondria-associated endoplasmic reticulum membranes.

A novel Skp2 inhibitor triggers pyroptosis in leukemia via phospholipid metabolism disorder and mitochondria-associated endoplasmic reticulum membranes.

Journal: Archives of pharmacal research

Published: November 04, 2025

Targeting MYC in T-Cell lymphoma via epigenetic modulation with a small-molecule inhibitor.

Targeting MYC in T-Cell lymphoma via epigenetic modulation with a small-molecule inhibitor.

Journal: Molecular cancer

Published: September 19, 2025

Showing 1-12 of 177

Last Updated: 09/26/2026